Fluticasone Nasal Spray Contraindications
Fluticasone propionate nasal spray is contraindicated only in patients with a known hypersensitivity to fluticasone or any component of the formulation. 1, 2, 3
Absolute Contraindication
- Hypersensitivity reaction: Do not use fluticasone nasal spray in any patient who has experienced an allergic reaction to fluticasone propionate or any ingredient in the formulation. 1, 2, 3
- Signs of hypersensitivity include sudden swelling of the face or tongue, rash, wheezing, or feeling faint—if these occur, stop the medication immediately and seek emergency care. 3
Situations Requiring Physician Consultation Before Use
While not absolute contraindications, the following scenarios require discussion with a physician or pharmacist before initiating fluticasone nasal spray:
- HIV protease inhibitors (e.g., ritonavir): Concomitant use may increase systemic fluticasone exposure due to CYP3A4 inhibition, potentially leading to Cushing syndrome and adrenal suppression. 3
- Ketoconazole (oral antifungal): This potent CYP3A4 inhibitor can significantly elevate fluticasone plasma levels. 3
- Concurrent systemic corticosteroid use: Patients already taking oral, inhaled, or topical steroids for asthma, allergies, skin conditions, or eye disorders should consult their physician to avoid cumulative corticosteroid burden. 3
Clinical Scenarios Requiring Immediate Discontinuation
- Active untreated nasal infections: Stop fluticasone and see a physician if severe sinus pain or thick nasal discharge suggests bacterial sinusitis. 3
- Recent nasal surgery or trauma: Intranasal corticosteroids should be avoided until complete healing occurs to prevent impaired wound healing. 4
- Exposure to varicella or measles: Discontinue fluticasone and consult a physician if the patient has active chickenpox, measles, or tuberculosis, or has been exposed to someone with these infections. 3
- Severe or recurrent epistaxis: Persistent nosebleeds or a constant whistling sound (suggesting septal perforation) warrant immediate cessation and otolaryngology evaluation. 3
Age-Related Restrictions
- Children under 4 years: Fluticasone propionate nasal spray is not FDA-approved for children younger than 4 years. 1, 2
- Alternative agents for ages 2–3 years: Mometasone furoate (Nasonex) or fluticasone furoate (Veramyst) are approved for children ≥2 years if intranasal corticosteroid therapy is indicated. 1, 2
Important Caveats
- Not for asthma or cold symptoms: Fluticasone nasal spray treats only allergic rhinitis—it is not indicated for asthma management or common cold symptoms. 3
- Pregnancy considerations: While intranasal fluticasone propionate may be used during pregnancy, fluticasone furoate, mometasone, or budesonide are preferred due to stronger safety data at recommended doses. 5
- No contraindication for hypertension: Unlike oral decongestants, fluticasone nasal spray does not elevate blood pressure and can be used safely in hypertensive patients without additional monitoring. 4, 3
Common Pitfall to Avoid
Do not confuse the contraindications for parenteral (injectable) corticosteroids—which are absolutely contraindicated for rhinitis due to prolonged adrenal suppression risk 4—with the safety profile of intranasal fluticasone, which has negligible systemic absorption and no clinically significant HPA-axis effects at recommended doses. 6, 7